Upgrade to SI Premium - Free Trial

Protagonist Therapeutics (PTGX) PT Raised to $190 at BMO Capital

September 1, 2026 7:35 AM
(Updated - September 1, 2026 9:09 AM EDT)

BMO Capital analyst Evan David Seigerman raised the price target on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change